Recombinant Human Anti-SFTSV Antibody (MAb4-5)
CAT#: HPAB-0032-WJ
This product is a human monoclonal IgG1 kappan antibody targeting Gnl domain of glycoprotein N (Gn) of severe fever with thrombocytopenia syndrome virus (SFTSV). This antibody shows the ability to SFTSV broad spectrum, using the antibody neutralization of the SFTSV, which made antibody specific drugs, and so as to be clinically useful in the prevention SFTSV by the treatment studies of diseases caused by infection, it has a strong clinical and economic value.
Published Data
Tested Data
ELISA
Figure 6 Ab10 also bound to Gn glycoprotein of HB29 and SD4 strains with comparable affinity to that of Gangwon/Korea 2012.
Binding properties of human IgG1 monoclonal antibody Ab10 (A) and MAb4-5 (B) to the recombinant Gn glycoprotein ectodomain of Gangwon/Korea 2012, HB29, and SD4 strains were measured by enzyme-linked immunosorbent assay (ELISA). Non-linear regression curves were fitted to a one site specific saturation binding model and the mean absorbance at 450 nm with standard deviation (s.d.) error bars are shown at each antibody concentration.
Kim, K. H., Kim, J., Ko, M., Chun, J. Y., Kim, H., Kim, S., ... & Chung, J. (2019). An anti-Gn glycoprotein antibody from a convalescent patient potently inhibits the infection of severe fever with thrombocytopenia syndrome virus. PLoS pathogens, 15(2), e1007375.
❮
❯
ELISA
Figure 1 Recombinant Human Anti-SFTSV Antibody (MAb4-5) (HPAB-0032-WJ) in ELISA.
ELISA analysis of HPAB-0032-WJ was performed by coating with recombinant SFTS virus Gn Protein (HN6), His Tag.
WB
Figure 2 Recombinant Human Anti-SFTSV Antibody (MAb4-5) (HPAB-0032-WJ) in WB.
WB analysis of HPAB-0032-WJ was performed by loading 0.1 µg (lane 1), 0.3 µg(lane 2), and 0.6 µg (lane 3) recombinant SFTS virus Gn Protein (HN6), His Tag onto a 12% Tris-HCl polyacrylamide gel.
SDS-PAGE
Figure 3 Recombinant Human Anti-SFTSV Antibody (MAb4-5) (HPAB-0032-WJ) in SDS-PAGE.
SDS-PAGE analysis of HPAB-0032-WJ in non-reduced and reduced conditions. Gel stained for 30 minutes with Coomassie Blue. As a result of different β-mercaptoethanol-reduced proteins (Heavy chain and Light chain) migrate as about 50 kDa and 25 kDa, respectively.
SEC-HPLC
Figure 4 Recombinant Human Anti-SFTSV Antibody (MAb4-5) (HPAB-0032-WJ) in SEC-HPLC.
The purity of HPAB-0032-WJ was 97.7428% as determined by SEC-HPLC.
❮
❯
Specifications
- Immunogen
- Purified SFTSV virus
- Host Species
- Human
- Derivation
- Phage display library
- Type
- Human IgG1
- Specificity
- SFTSV Gnl domain of glycoprotein N
- Species Reactivity
- SFTSV
- Clone
- MAb4-5
- Applications
- Neut, ELISA, WB, SPR, IF, EM
- Related Disease
- SFTSV infection diseases
Applications
- Application Notes
- The SFTSV antibody has been reported in applications of Neutralization, Enzyme-linked Immunosorbent Assay, Western Blot, Surface Plasmon Resonance, Immunofluorescence, Electron Microscopy.
For Neutralization: Fifty-microliters of twofold serial-diluted MAb 4–5 or control antibody (Ebola monoclonal antibody 13C6) was mixed with equal volume of 100 TCID50 SFTSV (SDYY007), or RVFV (BJ01) at 310 K for 1 h. The virus–antibody mixture was then transferred to 80% confluent Vero cells in a 96-well plate and incubated at 310 K for 1 h. The plate was washed with DMEM three times, and incubated at 310 K in a 5% CO2 incubator. Cytopathic effects were observed every 24 h for 6 d. The antibody was considered as having neutralizing capacity if 100% of viral cytopathic effects was inhibited.
For SPR: For the SPR assays, a BIAcore 3000 spectrometer was used to measure kinetic constants at room temperature (298 K). All proteins were exchanged into a buffer of 20 mM Hepes, pH 7.4, 150 mM NaCl and 0.005% (vol/vol) Tween 20. MAb 4–5 proteins were immobilized on CM5 chips at approximately 1,000 response units and analyzed for real-time binding by flowing through gradient concentrations (ranging from 7.8 to 1,000 nM) of Gn head proteins. For the Octet RED96 biosensor method, samples of buffer were dispensed into polypropylene 96-well black flat-bottom plates at a volume of 200 μL per well, and all measurements were performed at 298 K in HBS-EP buffer with the plate shaking at the speed of 1,000 rpm. Anti-human IgG Fc (AMC)-coated biosensor tips were used to capture antibody MAb 4–5 from 10 ng/μL stock buffer. The buffer was 20 mM Hepes, pH 7.4, 150 mM NaCl and 0.005% (vol/vol) Tween 20. Kinetic measurements for antigen binding were performed by exposing biosensors to a series of analyte concentrations (15.6−250 nM for Gn wild-type, and 15.6–500 nM for Gn mutants) and background subtraction was used to correct for sensor drifting. All sensors were generated with 10 mM Glycine-HCl, (pH 1.7,).
For Western Blot: To determine the binding target of the selected MAb 4-5 IgG1, purified SFTSV strain JS-2010-003 virions were lysed with sample buffer and proteins were fractionated by 10% SDS-PAGE. The separated proteins were electrotransferred to a nitrocellulose (NC) membrane and incubated consequently with MAb 4-5 IgG1 and horseradish peroxidase (HRP)-conjugated goat anti-human immunoglobulin. The blots were visualized by 3,3′diaminobenzidine (DAB) according to the manufacturer's instructions.
For IF: Reactivity between human MAb 4-5 IgG1 and SFTSV-infected cells was assessed using indirect immunofluorescence assay (IFA). The infected and noninfected (SFTSV, JS-2010-003) Vero cells were grown on an 8-well Millicell EZ slide for 36 h at 37°C, and cells were fixed by treatment with acetone for 10 min at −20°C. Human MAb 4-5 IgG1or an irrelevant human IgG1 (described above) were incubated with the fixed cells for 30 min at 37°C. Bound antibodies were detected using fluorescein isothiocyanate (FITC)-conjugated anti-human antibodies (diluted by phosphate-buffered saline PBS containing 0.01% [wt/vol] Evens blue) and observed under an immunofluorescence microscope.
For EM: SFTSV JS-2010-003 from the supernatant of infected Vero cells was adsorbed to copper grids coated with carbon and Pioloform. These were incubated with MAb 4-5 IgG1 by floating on droplets for 30 min at room temperature, and an irrelevant human IgG1 was used as a negative control. Bound monoclonal antibodies were detected by incubation on droplets of anti-human IgG gold 10-nm conjugates. The grids were negatively contrasted with 2% phosphotungstic acid and assessed with a Hitachi 7650A transmission electron microscope.
For ELISA: In order to measure the binding activities of the MAb4-5 IgG1 antibodies, 96-well half-area microplates were coated with Gn-Fc fusion protein and incubated at 4°C overnight. Plates were blocked with 3% skim milk in PBS for 1 h at room temperature. The plates were then washed with PBS and received antibodies that were 10-fold serially diluted from 1 μM to 10 μM in blocking buffer. The plates were then incubated for 2 h at room temperature and washed three times with 0.05% Tween20 in PBS solution. Then, 50 μL of HRP-conjugated anti-human Ig kappa light chain antibody diluted in blocking buffer (1:5000) was added into each well. Then, plates were incubated for 1 h at room temperature. After washing, each well received 50 μL of 3,3′,5,5′-tetramethylbenzidine (TMB) substrate solution. The color reaction was stopped by adding 50 μL of 2 M sulfuric acid. The absorbance of each well was measured at 450 nm using a microplate spectrophotometer .
Target
- Alternative Names
- thrombocytopenia syndrome virus; SFTSV
REVIEWS AND Q&AS
CITATIONS
RESOURCES
DOWNLOADS
RELATED PRODUCTS
Inquiry
Navs
Customer Review
There are currently no Customer reviews or questions for HPAB-0032-WJ. Click the button above to contact us or submit your feedback about this product.
Impressive Specificity
Having used this Anti-SFTSV antibody in my lab's Neutralization studies, I've consistently found it delivers impressive specificity and sensitivity. It accurately targets the glycoprotein region of SFTSV, providing reliable data that has greatly aided in our research on viral pathogenesis.
Reliable Performance
The performance of this antibody in ELISA applications has been remarkably reliable. Its high binding affinity allows for detailed examination of viral interactions, making it a staple in our virology studies.
Perfect for SFTSV Research
Focusing on SFTSV, this antibody has been indispensable. Its efficient neutralizing capabilities have enhanced our understanding of viral mechanism and pathogen-host interaction.
Q&As
-
What are the primary applications of this Anti-SFTSV Antibody?
A: This antibody is versatile and can be used in various applications such as Neutralization (Neut), Enzyme-Linked Immunosorbent Assay (ELISA), Western Blotting (WB), Surface Plasmon Resonance (SPR), Immunofluorescence (IF), and Electron Microscopy (EM). These applications make it valuable for studying viral interactions and immune responses.
-
What makes this antibody relevant for researching viral pathogens?
A: The antibody targets the Gnl domain of glycoprotein N of the severe fever with thrombocytopenia syndrome virus (SFTSV), making it a crucial tool for researchers studying this and related viral pathogens.
-
Does this antibody have any known cross-reactivity with other bacterial proteins?
A: This antibody is specifically designed to target H. pylori CagA protein, minimizing cross-reactivity with proteins from other bacteria. However, it's recommended to include appropriate controls in experiments to confirm specificity.
View the frequently asked questions answered by Creative Biolabs Support.
Cite This Product
To accurately reference this product in your publication, please use the following citation information:
(Creative Biolabs Cat# HPAB-0032-WJ, RRID: AB_3111346)
Copy citation
Submit Your Publication
Published with our product? Submit your paper and receive a 10% discount on your next order! Share your research to earn exclusive rewards.
Downloadable Resources
Download resources about recombinant antibody development and antibody engineering to boost your research.
Product Notes
This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:
• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production
See more details about Hi-Affi™ recombinant antibody benefits.
Datasheet
MSDS
COA
Certificate of Analysis LookupTo download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.
Lot Number:
Protocol & Troubleshooting
We have outlined the assay protocols, covering reagents, solutions, procedures, and troubleshooting tips for common issues in order to better assist clients in conducting experiments with our products. View the full list of Protocol & Troubleshooting.
See other products for "Clone MAb4-5"
- CAT
- Product Name
See other products for "SFTSV"
Select a product category from the dropdown menu below to view related products.
| CAT | Product Name | Application | Type |
|---|---|---|---|
| HPAB-0032-WJ-S(P) | Recombinant Human Anti-SFTSV Antibody scFv Fragment (MAb4-5) | Neut, ELISA, WB | Human scFv |
| CAT | Product Name | Application | Type |
|---|---|---|---|
| HPAB-0032-WJ-F(E) | Recombinant Human Anti-SFTSV Antibody Fab Fragment (MAb4-5) | Neut, ELISA, WB | Human Fab |
Specific Inquiry
Add to compare
See Our Custom Production in Action
Popular Products
Application: FC, Cyt, Stim, PP, Agonist
Application: WB, IF, IP, Neut, FuncS, ELISA, FC
Application: ELISA, FC, IP, FuncS, IF, Neut, ICC
Application: Block, Cyt, FuncS, Inhib
Application: WB, ELISA, FuncS
Application: WB, IF, FuncS
Application: WB, ELISA, Neut, FuncS
Application: ELISA, IHC, FC, IP, IF, BL
Application: ELISA, IHC, FC, IP, IF, FuncS
Application: ELISA, FC, IF, IHC, WB
Application: ELISA, Neut
Application: IF, ICC, WB, IHC-P, IP
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
Send Inquiry
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
